We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Sugar Lights Cancer Cells in MRI Scanners

By MedImaging International staff writers
Posted on 11 Jul 2013
Image: MRI detecting the uptake of sugar in tumors (Photo courtesy of UCL).
Image: MRI detecting the uptake of sugar in tumors (Photo courtesy of UCL).
A new study suggests that cancerous tumors can be detected by imaging the consumption of sugar with magnetic resonance imaging (MRI).

Researchers at University College London (UCL; United Kingdom) developed a noninvasive technique called the glucose chemical exchange saturation transfer (glucoCEST) for MRI imaging of glucose uptake in vivo in a murine model, based on the exchange of protons between hydroxyl groups and water. The method differs from existing molecular imaging methods since it permits detection of the delivery and uptake of a metabolically active compound in physiological quantities.

The glucoCEST technique has been found to be sensitive to tumor glucose accumulation in colorectal tumor models, and can distinguish tumor types with differing metabolic characteristics and pathophysiologies. The method uses an injection of normal sugar and could offer a cheap, safe alternative to existing methods for detecting tumors, which require the injection of radioactive material. The study was published online ahead of print on July 7, 2013, in Nature Medicine.

“Our research reveals a useful and cost-effective method for imaging cancers using MRI – a standard imaging technology available in many large hospitals,” said senior author Prof. Mark Lythgoe, PhD, director of the UCL Center for Advanced Biomedical Imaging (CABI). “In the future, patients could potentially be scanned in local hospitals, rather than being referred to specialist medical centers.”

“Our cross-disciplinary research could allow vulnerable patient groups such as pregnant women and young children to be scanned more regularly, without the risks associated with a dose of radiation,” added senior author Prof. Xavier Golay, PhD.

Most cancer cells predominantly produce energy by a high rate of glycolysis followed by lactic acid fermentation in the cytosol, rather than by comparatively low rate of glycolysis followed by oxidation of pyruvate in mitochondria, as in most normal cells. Tumors, therefore, have a greater reliance on anaerobic glycolysis for energy production than normal tissues, resulting in glycolytic rates up to 200 times higher than those of their normal tissues of origin—a phenomenon that is known as the Warburg effect.

Related Links:

University College London


Digital Radiographic System
OMNERA 300M
Portable Color Doppler Ultrasound Scanner
DCU10
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
X-Ray Illuminator
X-Ray Viewbox Illuminators

Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.